Vaccine News and Research

Latest Vaccine News and Research

Ad26.COV2.S vaccine effectiveness for preventing COVID-19

A group of multi-national researchers has expanded on previous research to conduct a preliminary evaluation of the effectiveness of the Ad26.COV2.S vaccine via HER data.

8 Nov 2021

Conspiracists during the COVID-19 pandemic

A researcher from the University of Pennsylvania has commented on how conspiracy theories misrepresent scientific data and advice.

8 Nov 2021

COVID-19 vaccination and deaths amongst US veterans

A new study studies the vaccine effectiveness and death in the Veterans Health Administration.

8 Nov 2021

More than 10 million people in the UK receive COVID-19 booster jabs

More than 10 million people have now received their COVID-19 booster or third jabs, the latest figures show, ensuring the vital protection they have secured from their first two doses is maintained over the winter months.

8 Nov 2021

Researchers explain why decaying SARS-CoV-2 antibodies in blood are not a problem after vaccination

A new study published in the preprint bioRxiv* server suggests vaccination helps to inflate the number of somatic hypermutations acquired by B cells. The increase in somatic hypermutations allows for an accumulation of highly matured bone marrow plasma cells.

8 Nov 2021

Rapid antibody response induced by mRNA COVID vaccines in mice

A new study posted in the bioRxiv* preprint server used mouse models to investigate how mRNA vaccines elicit a rapid antibody response. Their findings show two different mRNA vaccines successfully boost antibody levels — IL-5, IL-6, and MCP-1 —5 days after administration.

7 Nov 2021

Dramatic reduction in cervical cancer in the UK following the introduction of HPV vaccination

The current study assessed the impact of HPV vaccination on the rates of cervical cancer and cervical carcinoma in situ.

7 Nov 2021

New CDC report discusses efficacy of mRNA COVID vaccines in immunocompromised

The U.S. CDC reports the observed efficacy among the immunocompromised population following vaccination with mRNA vaccines against SARS-CoV-2.

7 Nov 2021

Oral SARS-CoV-2 Mpro inhibitor for therapeutic use

A new study describes a new small molecule compound that has shown impressive safety, tolerability, and bioavailability against SARS-CoV-2.

7 Nov 2021

Convalescent plasma post-vaccination increases binding and neutralizing antibodies against SARS-CoV-2 variants

A recent study assesses the boost in antibodies against SARS-CoV-2)variants post-vaccination in plasma samples from previously infected COVID-19 patients.

7 Nov 2021

Health and Social Care Secretary urges people in the UK to get COVID-19 booster jabs

Health and Social Care Secretary Sajid Javid has called for the UK to come together to help vaccinate those most vulnerable to COVID-19 with booster jabs.

7 Nov 2021

Booster booking system changed to make it easier for people to get their jab

The government and the NHS have changed the booster booking system to make it even easier for people to get their jab.

7 Nov 2021

GCH Pediatric Practice provides a model for addressing vaccine hesitancy and barriers

Golisano Children's Hospital Pediatric Practice in Rochester, NY demonstrated success in vaccinating eligible patients as well as their caregivers by offering the vaccine to both during pediatric visits, and provides a model for addressing vaccine hesitancy and barriers, according to an October 8th article published in JAMA Pediatrics' Viewpoint.

7 Nov 2021

Study discovers how the immune system triggers an 'emergency' dendritic cell response during infection

Scientists at the Francis Crick Institute have found how the immune system triggers an 'emergency' dendritic cell response during infection, with dendritic cells at the site of infection being reinforced by new cells which travel from the bone marrow.

6 Nov 2021

New type of COVID vaccine potentially easier to produce and does not need refrigeration

Currently available COVID vaccines require cold storage and sophisticated manufacturing capacity, which makes it difficult to produce and distribute them widely, especially in less developed countries.

6 Nov 2021

Researchers use suction method to deliver SARS-CoV-2 DNA vaccine in lab tests

Rutgers researchers studying COVID-19 have created a new way to deliver DNA molecules into skin cells, using a suction technique similar to the ancient healing practice of cupping.

6 Nov 2021

MHRA approves first oral antiviral for the treatment of COVID-19

The antiviral Lagevrio (molnupiravir) is safe and effective at reducing the risk of hospitalization and death in people with mild to moderate COVID-19 who are at increased risk of developing severe disease, the Medicines and Healthcare products Regulatory Agency announced today.

4 Nov 2021